| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |